ReviewCureus2022
Mycotic Thoracic Aortic Aneurysm: Epidemiology, Pathophysiology, Diagnosis, and Management.
Review in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 34 citations in OpenAlex.
- Thoracic Mycotic Aortic Aneurysm with Aortoesophageal Fistula and Uniformly Fatal Outcomes, a Case Series and Focused Literature Review.Acta Cardiologica Sinica · 2026Article
- Mid-ascending aortic pseudoaneurysm causing left main coronary artery compression in a patient with a history of tuberculosis.Journal of cardiothoracic surgery · 2026Article
- Infected Thoracic Aneurysm with Progressive Exudative Unilateral Pleural Effusion: A Case Report and Literature Review.Internal medicine (Tokyo, Japan) · 2026Review
- Article
- Collateral anastomosis in Leriche syndrome complicated by presumed mycotic thoracoabdominal aneurysm.Radiology case reports · 2026Article
- Article
- Article
- Article
- Combined Surgical Management and Endovascular Repair of Aortic Arch Mycotic Pseudoaneurysm Secondary to Descending Necrotizing Mediastinitis.Annals of thoracic surgery short reports · 2025Article
- Thoracoabdominal aorta replacement for multiple mycotic aneurysms caused byJTCVS techniques · 2025Article
- A Hybrid Approach in Treating a Mycotic Aneurism Caused by MRSA: A Case Report.The American journal of case reports · 2025Article
- MSSA Thoracic Mycotic Aneurysm Repaired with TEVAR: A Case Report.Reports (MDPI) · 2025Article
- Endovascular Treatment for Aortic Diseases: Intercontinental Disparities.Current cardiology reports · 2025Review
- Decellularized Porcine Aorta as a Scaffold for Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells in Tissue Engineering.Stem cell reviews and reports · 2025Article
- Article
- Article
- Atherosclerotic Abdominal Aortic Aneurysms on Computed Tomography Angiography: A Narrative Review on Spectrum of Findings, Structured Reporting, Treatment, Secondary Complications and Differential Diagnosis.Diagnostics (Basel, Switzerland) · 2025Review
- Abscess and aneurysm: A case of tuberculous abscess causing an aortic pseudo-aneurysm.Radiology case reports · 2025Article
- Infected Paravisceral Aneurysm Repair with Parallel Stent Grafts.Vascular specialist international · 2025Article
- Exploring infectious aneurysms through a series of cases in a tertiary care unit in South India.F1000Research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycotic thoracic aortic aneurysm (MTAA) is an aneurysm of the aorta caused by infection of the vessel tissue through microbial inoculation of the diseased aortic endothelium. It is most commonly caused by bacteria. Rarely, it can be caused by fungi. However, viral aortic aneurysm has never been reported. Depending on the area and time period investigated, the infections organism discovered may vary significantly. Little is known about the natural history of MTAA due to its rarity. It is not known if they follow the same pattern as other TAAs. However, it is unclear whether MTAA follows a similar clinical course. The combination of clinical presentation, laboratory results, and radiographic results are used to make the diagnosis of MTAA. Treatment of MTAA is complex since patients frequently present at a late stage, frequently with fulminant sepsis, as well as concomitant complications such as aneurysm rupture. While medical treatment, including antibiotics, is recommended, surgery is still the mainstay of management. Surgery to treat MTAA is complicated and carries a high risk of morbidity and mortality and includes both open repairs and endovascular ones. In this review, we explore the etiology, pathogenesis, clinical presentations, diagnostic modalities as well as treatment management available for MTAA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.